Professor Shi Yuanyuan of our company was invited to attend the review meeting of major key projects of Zhongyuan Nanase Laboratory
On June 7, Professor Yan Xiyun, academician of Chinese Academy of Sciences, presided over the review meeting of major key projects of Henan Provincial Laboratory - Zhongyuan Nanase Laboratory. Professor Shi Yuanyuan, chairman of our company, was invited to attend the review meeting as a project expert. This major key project review meeting aims to support researchers to carry out in-depth and systematic innovative research and transformation of results, and promote important breakthroughs in important fields or scientific frontiers.
Shenzhen Cell Valley also applied for the clinical study of cell therapy for acute myeloid leukemia this time. Dr. Zhao Lijun, director of R&D Department, as the respondent, elaborated the project background, feasibility analysis, technical route, preliminary basis and expected goals. The project aims to breakthrough the treatment of acute myeloid leukemia through new targets and CAR design. Cooperate with the academician team from basic research to clinical application transformation, combined with the development trend of the frontier of biomedicine, make breakthroughs in the original basic theoretical research and achievement transformation, create the Central Plains cell therapy highland, and truly benefit patients.
Zhongyuan Nanase Laboratory was established in October 2023, and the director of the laboratory is Yan Xiyun, an academician of the Chinese Academy of Sciences. The laboratory is led by Henan Academy of Medical Sciences, Zhengzhou University and Henan University, integrating the scientific and technological resources of Henan Agricultural University and the First Affiliated Hospital of Zhengzhou University and other universities and research institutes. In accordance with the principle of "complementary advantages", Zhongyuan Nanase Laboratory will industrialize the preparation of nitrogen-fixing nanase through the world's unique core technology route. To build a world-leading basic theoretical research platform, common technology research and development platform and science and technology enterprise incubation platform for nanofase, build a world-class nanofase innovation highland, build a world-renowned service base for biotechnology research and development and application industrialization, and open up a new path for high-quality development of the biomedical industry. In the future, a number of nanofase related high-tech enterprises will be incubated. Strive to promote nano-enzyme technology for the benefit of the people.
Shenzhen Cell Valley also applied for the clinical study of cell therapy for acute myeloid leukemia this time. Dr. Zhao Lijun, director of R&D Department, as the respondent, elaborated the project background, feasibility analysis, technical route, preliminary basis and expected goals. The project aims to breakthrough the treatment of acute myeloid leukemia through new targets and CAR design. Cooperate with the academician team from basic research to clinical application transformation, combined with the development trend of the frontier of biomedicine, make breakthroughs in the original basic theoretical research and achievement transformation, create the Central Plains cell therapy highland, and truly benefit patients.
Zhongyuan Nanase Laboratory was established in October 2023, and the director of the laboratory is Yan Xiyun, an academician of the Chinese Academy of Sciences. The laboratory is led by Henan Academy of Medical Sciences, Zhengzhou University and Henan University, integrating the scientific and technological resources of Henan Agricultural University and the First Affiliated Hospital of Zhengzhou University and other universities and research institutes. In accordance with the principle of "complementary advantages", Zhongyuan Nanase Laboratory will industrialize the preparation of nitrogen-fixing nanase through the world's unique core technology route. To build a world-leading basic theoretical research platform, common technology research and development platform and science and technology enterprise incubation platform for nanofase, build a world-class nanofase innovation highland, build a world-renowned service base for biotechnology research and development and application industrialization, and open up a new path for high-quality development of the biomedical industry. In the future, a number of nanofase related high-tech enterprises will be incubated. Strive to promote nano-enzyme technology for the benefit of the people.